TY - JOUR
T1 - Conformational analysis of the broad-spectrum antibacterial peptide, ranatuerin-2CSa
T2 - Identification of a full length helix-turn-helix motif
AU - Subasinghage, Anusha P.
AU - Conlon, J. Michael
AU - Hewage, Chandralal M.
PY - 2008/6
Y1 - 2008/6
N2 - Design of clinically valuable antibacterial agents based upon naturally occurring peptides requires the use of spectroscopic methods, particularly NMR, to determine the three-dimensional structure of the native peptide so that analogues with improved therapeutic properties can be made. Ranatuerin-2CSa (GILSSFKGVAKGVAKDLAG KLLETLKCKITGC), first isolated from skin secretions of the Cascades frog, Rana cascadae, represents a promising candidate for drug development. The peptide shows potent growth inhibitory activity against Escherichia coli (MIC = 5 μM) and Staphylococcus aureus (MIC = 10 μM) but displays haemolytic activity against human erythrocytes (LC50 = 160 μM). The solution structure of ranatuerin-2CSa was investigated by proton NMR spectroscopy and molecular modelling. In aqueous solution, the peptide lacks secondary structure but, in a 2,2,2-trifluoroethanol (TFE-d3)-H2O solvent mixture, the structure is characterised by a full length helix-turn-helix conformation between residues I2-L21, L22-L25 and K26-T30 respectively. This structural information will facilitate the design of novel therapeutic agents based upon the ranatuerin-2CSa structure with improved antimicrobial potencies but decreased cytolytic activities against mammalian cells.
AB - Design of clinically valuable antibacterial agents based upon naturally occurring peptides requires the use of spectroscopic methods, particularly NMR, to determine the three-dimensional structure of the native peptide so that analogues with improved therapeutic properties can be made. Ranatuerin-2CSa (GILSSFKGVAKGVAKDLAG KLLETLKCKITGC), first isolated from skin secretions of the Cascades frog, Rana cascadae, represents a promising candidate for drug development. The peptide shows potent growth inhibitory activity against Escherichia coli (MIC = 5 μM) and Staphylococcus aureus (MIC = 10 μM) but displays haemolytic activity against human erythrocytes (LC50 = 160 μM). The solution structure of ranatuerin-2CSa was investigated by proton NMR spectroscopy and molecular modelling. In aqueous solution, the peptide lacks secondary structure but, in a 2,2,2-trifluoroethanol (TFE-d3)-H2O solvent mixture, the structure is characterised by a full length helix-turn-helix conformation between residues I2-L21, L22-L25 and K26-T30 respectively. This structural information will facilitate the design of novel therapeutic agents based upon the ranatuerin-2CSa structure with improved antimicrobial potencies but decreased cytolytic activities against mammalian cells.
KW - Antimicrobial
KW - Molecular modelling
KW - NMR
KW - Ranatuerin-2
UR - http://www.scopus.com/inward/record.url?scp=43649109015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43649109015&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2008.02.019
DO - 10.1016/j.bbapap.2008.02.019
M3 - Article
C2 - 18387372
AN - SCOPUS:43649109015
SN - 1570-9639
VL - 1784
SP - 924
EP - 929
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 6
ER -